241 related articles for article (PubMed ID: 19173823)
21. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.
Li H; Zhu X; Zhang Y; Xiang J; Chen H
J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237
[TBL] [Abstract][Full Text] [Related]
22. Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.
Liu F; Shang Y; Chen SZ
Acta Pharmacol Sin; 2014 May; 35(5):645-52. PubMed ID: 24727941
[TBL] [Abstract][Full Text] [Related]
23. Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models.
Higgins B; Kolinsky K; Smith M; Beck G; Rashed M; Adames V; Linn M; Wheeldon E; Gand L; Birnboeck H; Hoffmann G
Anticancer Drugs; 2004 Jun; 15(5):503-12. PubMed ID: 15166626
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of selective MEK1/2 inhibitor AZD6244 in combination with PI3K/mTOR inhibitor BEZ235 in gefitinib-resistant NSCLC xenograft models.
Qu Y; Wu X; Yin Y; Yang Y; Ma D; Li H
J Exp Clin Cancer Res; 2014 Jun; 33(1):52. PubMed ID: 24939055
[TBL] [Abstract][Full Text] [Related]
25. TNF-related apoptosis-inducing ligand enhances vinorelbine-induced apoptosis and antitumor activity in a preclinical model of non-small cell lung cancer.
Zhu K; Fang W; Chen Y; Lin S; Chen X
Oncol Rep; 2014 Sep; 32(3):1234-42. PubMed ID: 25017445
[TBL] [Abstract][Full Text] [Related]
26.
Yang H; Tong Z; Shen L; Sun YU; Hoffman RM; Huang J
Anticancer Res; 2020 Sep; 40(9):4969-4978. PubMed ID: 32878785
[TBL] [Abstract][Full Text] [Related]
27. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
[TBL] [Abstract][Full Text] [Related]
28. Gefitinib and chemotherapy combination studies in five novel human non small cell lung cancer xenografts. Evidence linking EGFR signaling to gefitinib antitumor response.
Judde JG; Rebucci M; Vogt N; de Cremoux P; Livartowski A; Chapelier A; Tran-Perennou C; Boye K; Defrance R; Poupon MF; Bras-Gonçalves RA
Int J Cancer; 2007 Apr; 120(7):1579-90. PubMed ID: 17205515
[TBL] [Abstract][Full Text] [Related]
29. Experimental study of combination therapy with S-1 against pancreatic cancer.
Yoshizawa J; Takizawa A; Takeuchi O; Hiraku O; Sasaki K; Morimoto Y; Atsuda K; Inoue G; Suzuki Y; Asanuma F; Yamada Y
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1211-9. PubMed ID: 19337733
[TBL] [Abstract][Full Text] [Related]
30. Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
Kraus-Berthier L; Jan M; Guilbaud N; Naze M; Pierré A; Atassi G
Clin Cancer Res; 2000 Jan; 6(1):297-304. PubMed ID: 10656461
[TBL] [Abstract][Full Text] [Related]
31. Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.
Takeda Y; Wada T; Nishitani Y; Matsumoto M; Hojo K; Maekawa R; Yoshioka T
Cancer Lett; 2002 Aug; 182(1):61-8. PubMed ID: 12175524
[TBL] [Abstract][Full Text] [Related]
32. Biweekly cisplatin and gemcitabine with two different doses in non small cell lung cancer patients: A retrospective singlecenter experience.
Dogan E; Ucar M; Sakalar T; Derin S; Bozkurt O; Inanc M; Ozkan M
J BUON; 2018; 23(4):1070-1076. PubMed ID: 30358213
[TBL] [Abstract][Full Text] [Related]
33. [A randomized comparative trial of three combined regimens containing cisplatin for treatment of advanced non-small cell lung cancer].
Liu L; Wang XW; Li L; Zhang X; Zhang WD; Yu XJ
Ai Zheng; 2006 Aug; 25(8):990-4. PubMed ID: 16965680
[TBL] [Abstract][Full Text] [Related]
34. Synergistic activity of combination therapy with PEGylated pemetrexed and gemcitabine for an effective cancer treatment.
Vandana M; Sahoo SK
Eur J Pharm Biopharm; 2015 Aug; 94():83-93. PubMed ID: 25968494
[TBL] [Abstract][Full Text] [Related]
35. Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine.
Vansteenkiste J; Vandebroek J; Nackaerts K; Dooms C; Galdermans D; Bosquée L; Delobbe A; Deschepper K; Van Kerckhoven W; Vandeurzen K; Deman R; D'Odemont JP; Siemons L; Van den Brande P; Dams N;
Lung Cancer; 2003 May; 40(2):191-9. PubMed ID: 12711121
[TBL] [Abstract][Full Text] [Related]
36. Gemcitabine (GEM) and carboplatin (CBDCA) versus cisplatin (CDDP) and vinblastine (VLB) in advanced non-small-cell lung cancer (NSCLC) stages III and IV: a phase III randomised trial.
Grigorescu AC; Draghici IN; Nitipir C; Gutulescu N; Corlan E
Lung Cancer; 2002 Jul; 37(1):9-14. PubMed ID: 12057861
[TBL] [Abstract][Full Text] [Related]
37. Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial.
Binder D; Schweisfurth H; Grah C; Schäper C; Temmesfeld-Wollbrück B; Siebert G; Suttorp N; Beinert T
Cancer Chemother Pharmacol; 2007 Jun; 60(1):143-50. PubMed ID: 17031643
[TBL] [Abstract][Full Text] [Related]
38. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
[TBL] [Abstract][Full Text] [Related]
39. Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?
De Luca A; Grassii M; Maiello MR; Di Maio M; Mancino M; De Maio E; Gridelli C; Perrone F; Normanno N
Anticancer Res; 2004; 24(5A):2985-9. PubMed ID: 15517905
[TBL] [Abstract][Full Text] [Related]
40. Bufalin induces apoptosis in vitro and has Antitumor activity against human lung cancer xenografts in vivo.
Wu SH; Bau DT; Hsiao YT; Lu KW; Hsia TC; Lien JC; Ko YC; Hsu WH; Yang ST; Huang YP; Chung JG
Environ Toxicol; 2017 Apr; 32(4):1305-1317. PubMed ID: 27444971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]